PetIQ - PETQ Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for PetIQ in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PETQ shares.
View PETQ analyst ratings or view top-rated stocks.

3 brokers have issued 12 month price objectives for PetIQ's shares. Their PETQ share price forecasts range from $16.00 to $30.00. On average, they anticipate the company's share price to reach $21.75 in the next year. This suggests a possible upside of 93.7% from the stock's current price.
View analysts price targets for PETQ or view top-rated stocks among Wall Street analysts.

PetIQ's stock was trading at $9.22 at the start of the year. Since then, PETQ stock has increased by 21.8% and is now trading at $11.23.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023.
View our PETQ earnings forecast.

PetIQ, Inc. (NASDAQ:PETQ) posted its earnings results on Tuesday, February, 28th. The company reported ($0.18) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.26) by $0.08. The firm earned $184.08 million during the quarter, compared to analysts' expectations of $191.80 million. PetIQ had a positive trailing twelve-month return on equity of 9.72% and a negative net margin of 5.23%.

ProShares Pet Care ETF holds 59,441 shares of PETQ stock, representing 0.70% of its portfolio.

PetIQ issued an update on its first quarter 2023 earnings guidance on Tuesday, February, 28th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $270.00 million-$290.00 million, compared to the consensus revenue estimate of $273.58 million.

10 employees have rated PetIQ Chief Executive Officer Cord Christensen on Glassdoor.com. Cord Christensen has an approval rating of 89% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other PetIQ investors own include Micron Technology (MU), NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Exelixis (EXEL), Intel (INTC), CVS Health (CVS), QUALCOMM (QCOM), Editas Medicine (EDIT) and Gilead Sciences (GILD).

(PETQ) raised $86 million in an initial public offering (IPO) on Friday, July 21st 2017. The company issued 5,700,000 shares at a price of $14.00-$16.00 per share. Jefferies and William Blair acted as the underwriters for the IPO and Oppenheimer, Raymond James and SunTrust Robinson Humphrey were co-managers.

PetIQ trades on the NASDAQ under the ticker symbol "PETQ."

PetIQ's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Boston Partners (5.32%), Aristotle Capital Boston LLC (4.02%), Nepsis Inc. (3.03%), Fred Alger Management LLC (2.94%), Millennium Management LLC (2.65%) and Brandywine Global Investment Management LLC (2.47%). Insiders that own company stock include Allan Hall, John Newland, Mark L First, Mccord Christensen, Michael A Smith, Michael A Smith, Robert Michael Herrman, Ronald Kennedy, Susan Sholtis, Will Santana and Zvi Glasman.
View institutional ownership trends.

Shares of PETQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PETQ stock can currently be purchased for approximately $11.23.

PetIQ (NASDAQ:PETQ) has a market capitalization of $328.25 million and generates $921.51 million in revenue each year. The company earns $-48,210,000.00 in net income (profit) each year or ($1.65) on an earnings per share basis.

The company employs 1,888 workers across the globe.

PetIQ's mailing address is 923 S. Bridgeway Pl., EAGLE ID, 83616. The official website for the company is www.petiq.com. The company can be reached via phone at (208) 939-8900 or via email at jeff.sonnek@icrinc.com.